US Stock MarketDetailed Quotes

FDMT 4D Molecular Therapeutics

Watchlist
  • 3.600
  • -0.010-0.28%
Trading Mar 27 14:20 ET
166.69MMarket Cap-1.21P/E (TTM)

About 4D Molecular Therapeutics Company

4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. It combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV capsid-derived sequences. Its product design, development and manufacturing engine create a valuable and diverse product pipeline. The company is currently advancing five clinical-stage and two preclinical product candidates, each tailored to address rare and large market diseases. 4DMT was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.

Company Profile

SymbolFDMT
Company Name4D Molecular Therapeutics
Issue Price23.00
Founded2013
CEOMr. David Kirn, M.D.
MarketNASDAQ
Employees227
Fiscal Year Ends12-31
Address5858 Horton Street,Suite 455
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-505-2680
Websitehttp://www.4dmoleculartherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • David Kirn, M.D.
  • Director and Chief Executive Officer
  • 10.29M
  • Noriyuki Kasahara, M.D.,PhD
  • Chief Scientific Officer
  • 488.91K
  • Robert Young Kim, M.D.
  • Chief Medical Officer
  • 3.96M
  • Dr. Fariborz Kamal, PhD
  • President and Chief Operating Officer
  • 4.54M
  • Uneek Mehra
  • Chief Business Officer, Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. John F. Milligan, PhD
  • Executive Chairman of the Board
  • 581.44K
  • Susannah Gray, M.B.A.
  • Independent Director
  • 352.62K
  • Shawn Cline Tomasello, M.B.A.
  • Independent Director
  • 345.12K
  • Nancy Miller-Rich
  • Independent Director
  • 340.12K
  • Jacob M. Chacko, M.B.A.,M.D.
  • Independent Director
  • 352.62K
  • Dr. Charles P. Theuer, M.D.,PhD
  • Independent Director
  • 352.62K
  • Scott Bizily, J.D.,PhD
  • Chief Legal and Corporate Secretary
  • --

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
The9 Ltd
NCTY
14.6200
Bit Digital
BTBT
2.265
Argo Blockchain
ARBK
0.389
4
Abits
ABTS
3.200
5
Digihost Technology
DGHI
1.320
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025